These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2126613)

  • 1. Corticotropin-releasing factor concentrations exhibit an apparent diurnal rhythm in hypothalamic and extrahypothalamic brain regions: differential sensitivity to corticosterone.
    Owens MJ; Bartolome J; Schanberg SM; Nemeroff CB
    Neuroendocrinology; 1990 Dec; 52(6):626-31. PubMed ID: 2126613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of corticotropin-releasing factor and vasopressin in discrete brain regions after morphine administration: correlations with hypothalamic noradrenergic activity and pituitary-adrenal response.
    Milanés MV; Laorden ML; Chapleur-Château M; Burlet A
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):603-10. PubMed ID: 9402040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin releasing factor distribution in normal and Brattleboro rat brain, and effect of deafferentation, hypophysectomy and steroid treatment in normal animals.
    Krieger DT; Liotta A; Brownstein MJ
    Endocrinology; 1977 Jan; 100(1):227-37. PubMed ID: 11988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diurnal variation of corticotropin-releasing factor binding sites in the rat brain and pituitary.
    Fuchs E; Wasmuth JC; Flügge G; Huether G; Troost R; Beyer J
    Cell Mol Neurobiol; 1996 Feb; 16(1):21-37. PubMed ID: 8714557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of benzodiazepine agonist exposure on corticotropin-releasing factor content and hormonal stress responses: divergent responses in male and ovariectomized female rats.
    Wilson MA; Biscardi R; Smith MD; Wilson SP
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1073-82. PubMed ID: 8819488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
    Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
    Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: lack of effect in other rat brain regions.
    Haas DA; George SR
    Life Sci; 1987 Dec; 41(25):2725-31. PubMed ID: 2826949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing factor and type 1 corticotropin-releasing factor receptor messenger RNAs in rat brain and pituitary during "binge"-pattern cocaine administration and chronic withdrawal.
    Zhou Y; Spangler R; LaForge KS; Maggos CE; Ho A; Kreek MJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):351-8. PubMed ID: 8859013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress.
    Chappell PB; Smith MA; Kilts CD; Bissette G; Ritchie J; Anderson C; Nemeroff CB
    J Neurosci; 1986 Oct; 6(10):2908-14. PubMed ID: 3020187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of corticotropin-releasing factor in rat brain.
    Palkovits M; Brownstein MJ; Vale W
    Fed Proc; 1985 Jan; 44(1 Pt 2):215-9. PubMed ID: 3871409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sex difference in the circadian rhythm of corticotropin-releasing activity in the rat hypothalamus (author's transl)].
    Honma S
    Hokkaido Igaku Zasshi; 1976 Jan; 51(1):23-39. PubMed ID: 1084854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.
    Owens MJ; Knight DL; Ritchie JC; Nemeroff CB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):795-800. PubMed ID: 1847213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic norepinephrine depletion inhibits CRF-41 release following neural stimuli.
    Feldman S; Weidenfeld J
    Neuroreport; 1993 Dec; 5(3):258-60. PubMed ID: 8298085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin releasing factor (CRF): origin and course of afferent pathways to the median eminence (ME) of the rat hypothalamus.
    Merchenthaler I; Hynes MA; Vigh S; Schally AV; Petrusz P
    Neuroendocrinology; 1984 Oct; 39(4):296-306. PubMed ID: 6387524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the site of origin and molecular form of the extrahypothalamic corticotrophin-releasing factor (CRF) in rats.
    Yasuda N; Yasuda Y
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):145-52. PubMed ID: 2990130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing factor receptors and pituitary adrenal responses during immobilization stress.
    Hauger RL; Millan MA; Lorang M; Harwood JP; Aguilera G
    Endocrinology; 1988 Jul; 123(1):396-405. PubMed ID: 2838259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of corticotropin-releasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1- and vimentin-immunoreactive fibres.
    Henry BA; Lightman SL; Lowry CA
    J Neuroendocrinol; 2005 Mar; 17(3):135-44. PubMed ID: 15796765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role for brain corticotropin-releasing factor in the weight-reducing effects of chronic fenfluramine treatment in rats.
    Appel NM; Owens MJ; Culp S; Zaczek R; Contrera JF; Bissette G; Nemeroff CB; De Souza EB
    Endocrinology; 1991 Jun; 128(6):3237-46. PubMed ID: 1645265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic psychosocial stress enhances vasopressin, but not corticotropin-releasing factor, in the external zone of the median eminence of male rats: relationship to subordinate status.
    De Goeij DC; Dijkstra H; Tilders FJ
    Endocrinology; 1992 Aug; 131(2):847-53. PubMed ID: 1322285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of morphine on hypothalamic corticotropin-releasing factor (CRF) and pituitary-adrenocortical activity.
    Suemaru S; Hashimoto K; Ota Z
    Endocrinol Jpn; 1986 Aug; 33(4):441-8. PubMed ID: 3024953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.